2017
DOI: 10.1016/j.cmpb.2017.02.004
|View full text |Cite
|
Sign up to set email alerts
|

Classification of nervous system withdrawn and approved drugs with ToxPrint features via machine learning strategies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 51 publications
0
15
0
Order By: Relevance
“…Some studies also used AI to predict drug interactions by analyzing EHR data [ 88 ], unstructured discharge notes [ 90 ], and clinical charts [ 99 , 104 ]. One study also used AI to identify drugs that were withdrawn from the commercial markets by the FDA [ 100 ].…”
Section: Resultsmentioning
confidence: 99%
“…Some studies also used AI to predict drug interactions by analyzing EHR data [ 88 ], unstructured discharge notes [ 90 ], and clinical charts [ 99 , 104 ]. One study also used AI to identify drugs that were withdrawn from the commercial markets by the FDA [ 100 ].…”
Section: Resultsmentioning
confidence: 99%
“…The effective hyperplane is considered as a classifier line and the sample inputs which are nearest to the classification line are called support vector. The expression for the training set of the SVM classifier is [14,15]…”
Section: Machine Learning Algorithmsmentioning
confidence: 99%
“…Work has been carried out to predict compounds that will bind to this receptor [114] . In general, based on an equal number of drugs approved or withdrawn for the treatment of CNS pathologies, possible discriminative fragments have been studied that allow the search for other similar compounds for the treatment of CNS pathologies [115] .…”
Section: Biological Problems Asses By Machine Learning In Drug Discoverymentioning
confidence: 99%